Chinese biopharmaceutical firm CStone Pharmaceuticals is looking to raise as much as HK$2.2 billion ($282 million) in its upcoming Hong Kong IPO next week at an expected HK$12.6 billion ($1.6 billion) market cap.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
